Neutrophils, interleukin-17A and lung disease

European Respiratory Journal

Volumn 25, Issue 1, 2005, Pages 159-172

  Linden A ^a   Laan, M ^a   Anderson, G P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytotoxic T lymphocyte associated serine esterase 8; Innate immunity; Interleukin 17; T lymphocytes

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR; CYTOKINE; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17A; INTERLEUKIN 25; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; MUCIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

BIOACCUMULATION; BRONCHUS; CELL MOTILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; DRUG TARGETING; EVIDENCE BASED MEDICINE; GRANULOCYTE; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-17; LUNG DISEASES; LYMPHOCYTE ACTIVATION; MALE; NEUTROPHILS; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 13444302850     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00032904     Document Type: Review

References (187)

1. Rouvier E, Luciani MF, Mattei MG, Denizof F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpes virus saimiri gene. J Immunol 1993; 150: 5445-5456.
2. Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483-5486.
3. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 2347-2352.
4. Miyamoto M, Prause O, Laan M, Sjöstrand M, Lötvall J, Lindén A. Endogenous IL-17 mediates endotoxin-induced airway neutrophilia in mice in vivo. J Immunol 2003; 170: 4665-4672.
5. Vanaudenaerde BM, Wuyts WA, Dupont LJ, Van Raemdonck DE, Demedts MM, Verleden GM. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22: 1280-1283.
6. Molet S, Hamid QA, Davoine F, et al. Interleukin-17 is increased in asthmatic airways and induces human fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 103-109.
7. Numasaki M, Lotze MT, Sasaki H. Interleukin-17 augments tumour necrosis factor-α-induced elaboration of proangiogenic factors from fibroblasts. Immunol Lett 2004; 93: 39-43.
8. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593-2603.
9. Laan M, Lötvall J, Chung KF, Lindén A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001; 133: 200-206.
10. Kawaguchi M, Kokubu F, Kuga H, et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108: 804-809.
11. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527.
12. Hellings PW, Kasran A, Liu Z, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Crit Care Med 2003; 28: 42-50.
13. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced air-way neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170: 2106-2112.
14. Hoshino H, Laan M, Sjöstrand M, Lötvall J, Skoogh BE, Lindén A. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 2000; 105: 143-149.
15. Laan M, Prause O, Miyamoto M, et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α. Eur Respir J 2003; 21: 1-7.
16. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003; 278: 17036-17043.
17. Prause O, Bozinovski S, Anderson GP, Lindén A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 2004; 59: 313-317.
18. 4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nature Med 2001; 7: 465-470.
19. Shiohara M, Gombart AF, Sekiguchi Y, et al. Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency. J Leukoc Biol 2004; 75: 190-197.
20. Terregino CA, Lubkin CLL, Thom SR. Impaired neutrophil adherence as an early marker of systemic inflammatory response syndrome and severe sepsis. Ann Emerg Med 1997; 29: 400-403.
21. Meddows-Taylor S, Pendle S. Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis. J Infect Dis 2001; 183: 662-665.
22. Link H, Böhme A, Cornely OA, et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 2003; 82: Suppl. 2, S105-S117.
23. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000; 173: 39-51.
24. Schwartz DA. The genetics of innate immunity. Chest 2002; 121: 62S-68S.
25. Paterson HM, Murphy TJ, Purcell EJ, et al. Injury primes the innate system for enhanced Toll-like receptor reactivity. J Immunol 2003; 171: 1473-1483.
26. Calkins CM, Barsness K, Bensard DD, et al. Toll-like receptor-4 signaling mediates pulmonary neutrophil sequestration in response to Gram-positive bacterial enterotoxin. J Surg Res 2002; 104: 124-130.
27. Droemann D, Goldmann T, Branschield D, et al. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003; 119: 103-108.
28. Escotte S, Daniel C, Gaillard D, et al. Fluticasone propionate inhibits lipopolysaccharide-induced proinflammatory response in human cystic fibrosis airway grafts. J Pharmacol Exp Ther 2002; 302: 1151-1157.
29. Dinakar C, Malur A, Raychaudhuri B, et al. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann Allergy Asthma Immunol 1999; 82: 217-222.
30. Fahy JV, Kim KW, Liu JJ, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-852.
31. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Clinical and biological significance. Am J Respir Crit Care Med 2000; 161: 1185-1160.
32. Vignola AM, Bonanno A, Mirabella A, et al. Increased level of elastase and alpha 1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998; 157: 505-511.
33. Lamblin C, Gosset P, Tillie-Leblond I, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998; 157: 394-402.
34. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
35. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160: 1001-1008.
36. Gaga M, Bentely AM, Humbert M, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin-8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53: 685-691.
37. Angrill J, Augusti C, De Celis R, et al. Bronchial inflammation and colonisation in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001; 164: 1628-1632.
38. Zeng L, Shum H, Tipoe GL, et al. Macrophages, neutrophils and tumour necrosis factor-α expression in bronchiectatic airways in vivo. Respir Med 2001; 95: 792-798.
39. Saetta M, Turato G, Facchini F, et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1633-1639.
40. Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-365.
41. Balbi B, Bason C, Balleari E, et al. Increased bronchoalveolar granulocytes and granulocyte/colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 1997; 10: 846-850.
42. Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999; 159: 1985-1991.
43. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349-355.
44. Balzano G, Stefanelli F, Irorio C, et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1486-1492.
45. Di Stefano A, Capelli A, Lusardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1999; 158: 1277-1285.
46. Soler N, Ewig S, Torres A, Filella X, Gonzales J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 1015-1022.
47. Noguera A, Batle S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001; 56: 432-437.
48. Koller DY, Urbanek R, Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 629-633.
49. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry LL. Infection, inflammation and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 904-910.
50. Muhlebach MS, Noah TL. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 911-915.
51. Sagel SD, Kapsner R, Osberg I, Sontag MK, Accurso FJ. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med 2001; 164: 1425-1431.
52. Riise GC, Kjellström C, Ryd W, et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J 1997; 10: 1742-1746.
53. Riise GC, Andersson BA, Kjellström C, et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 1999; 14: 1123-1130.
54. Baugham R, Gunther KL, Rashkin MC, Keeton DA, Pattishal EN. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 1996; 154: 76-81.
55. Geerts L, Jorens PG, Willems J, De Ley M, Slegers H. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med 2001; 29: 1920-1924.
56. Cundall M, Sun Y, Miranda C, Trudeau JB, Barnes S, Wenzel SE. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 2003; 112: 1064-1071.
57. Baraldo S, Turato G, Badin C, et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 2003; 59: 308-312.
58. Vachier I, Vignola AM, Chiappara G, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004; 59: 303-307.
59. Stanescu D, Sanna A, Kostianev S, Calgagni PG, Fabbri LM, Maestrelli P. Airway obstruction, chronic expectoration, and rapid decline in FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
60. Betz R, Kohlhaufl M, Kassner G, et al. Increased sputum IL-8 and IL-5 in asymptomatic non-specific hyperresponsiveness. Lung 2001; 179: 119-133.
61. Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol 2001; 107: 623-626.
62. 4 in bronchial hyperresponsiveness induced by interleukin-8. Eur Respir J 1998; 11: 306-311.
63. Jeffrey PK, Venge P, Gizycki MJ, Egerod I, Dahl R, Faurschou P. Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. Eur Respir J 2002; 20: 1378-1385.
64. Matsumoto K, Aizawa H, Inoue H, Koto H, Nakano H, Hara N. Role of neutrophil elastase in ozone-induced airway responses in guinea-pigs. Eur Respir J 1999; 14: 1088-1094.
65. Suzuki T, Wang W, Lin JT, Shirato K, Mitsuhashi H, Inoue H. Aerosolised human neutrophil elastase induces airway constriction and hyper-responsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor. Am J Respir Crit Care Med 1996; 153: 1405-1411.
66. 3He diffusion. Proc Natl Acad Sci USA 2000; 10: 11478-11481.
67. Janoff A, Sloan B, Weinbaum G, et al. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977; 115: 461-478.
68. Sköld CM, Liu X, Umino T, et al. Human neutrophil elastase augments fibroblast-mediated contraction of released collagen gels. Am J Respir Crit Care Med 1999; 159: 1138-1146.
69. Zhu YK, Liu XD, Skold CM, et al. Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol 2001; 281: L868-L878.
70. Sommerhof CP, Nadel JA, Basbaum C, Caughey G. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland cells. J Clin Invest 2000; 85: 682-689.
71. Schuster A, Ueki I, Nadel JA. Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200,355. Am J Physiol 1992; 262: L86-L91.
72. 4-induced nasal gland serous secretion mediated by neutrophil elastase. Am J Respir Crit Care Med 1999; 160: 411-414.
73. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980; 66: 859-862.
74. Senior RM, Griffin GL, Mecham RP. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 1982; 70: 614-618.
75. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3: distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988; 82: 1963-1973.
76. Campanelli D, Melchior M, Fu Y, et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic and autoantigen from human neutrophils. J Exp Med 1990; 172: 1709-1715.
77. Fruh H, Kostoulas G, Michael BA, Baici A. Human myeloblastin (leukocyte proteinase 3): reactions with substrates, inactivators and activators in comparison with leukocyte elastase. J Biol Chem 1996; 377: 579-586.
78. Culpitt AV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1635-1639.
79. Adams JM, Hauser CJ, Livingston DH, Lavery RF, Fekete Z, Dietch EA. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis and organ failure. J Trauma 2001; 51: 452-456.
80. Ishizaka A, Watanabe M, Yamashita T, et al. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 2001; 29: 896-898.
81. Sagel SD, Sontag MK, Wagener JS, Kapsner RK, Osberg I, Accurso FJ. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr 2002; 141: 811-817.
82. Takafuji S, Ishida A, Miyakuni Y, Nakagawa T. Matrix metalloproteinase-9 release from human leukocytes. J Investig Allergol Clin Immunol 2003; 13: 50-55.
83. Claesson R, Johansson A, Belibasakis G, Hänström L, Kalfas S. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J Periodontal Res 2002; 37: 353-359.
84. Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002; 122: 1553-1559.
85. Wenzel SE, Balzar SB, Cundall M, Chu HW. Subepithelial basement membrane imunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003; 111: 1345-1352.
86. Prikk K, Maisis P, Pirila E, et al. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest 2002; 82: 1534-1545.
87. Cataldo DD, Tournoy KG, Vermaelen K, et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 2002; 161: 491-498.
88. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002; 122: 1543-1552.
89. Lee YC, Lee HB, Rhee YK, Song CH. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clin Exp Allergy 2001; 31: 1623-1630.
90. Cataldo D, Munuat C, Noel A, et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000; 123: 259-267.
91. 2+/calmodulin-dependent protein kinase II inhibitors potentiate superoxide production in polymorphonuclear leukocytes. J Pharm Pharmacol 1999; 51: 295-300.
92. Cortijo J, Villagrasa V, Pons R, et al. Bronchodilator and anti-inflammatory activities of glaucine: in vitro studies on human airway smooth muscle and polymorphonuclear leukocytes. Br J Pharmacol 1999; 127: 1641-1651.
93. Sustiel AM, Joseph B, Rocklin RE, Borish L. Asthmatic patients have neutrophils that exhibit diminished responsiveness to adenosine. Am Rev Respir Dis 1989; 140: 1556-1561.
94. Massion P, Lindén A, Inoue H, Mathy M, Grattan KM, Nadel JA. Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am J Physiol 1996; 271: L838-L843.
95. Inoue H, Aizawa H, Nakano H, et al. Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med 2000; 161: 249-256.
96. Stevens WH, Inman MD, Wattie J, O'Byrne PM. Allergen-induced oxygen radical release from bronchoalveolar lavage cells and airway hyperresponsiveness in dogs. Am J Respir Crit Care Med 1995; 151: 1526-1531.
97. Takahashi T, Miura M, Katsumata U, et al. Involvement of superoxide in ozone-induced airway hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1993; 148: 103-106.
98. Nakano H, Aizawa H, Matsumoto K, Fukuyama S, Inoue H, Hara N. Cyclooxygenase-2 participates in the late phase of airway hyperresponsiveness after ozone exposure in guinea pigs. Eur J Pharmacol 2000; 403: 267-275.
99. Matsui S, Jones GL, Woolley MJ, Lane CC, Gontovnick LS, O'Byrne PM. The effect of antioxidants on ozone-induced airway hyperresponsiveness in dogs. Am Rev Respir Dis 1991; 144: 1287-1290.
100. Hallahan AR, Armour CL, Black JL. Products of neutrophils and eosinophils increase the responsiveness of human isolated bronchial tissue. Eur Respir J 1990; 3: 554-558.
101. Volcano M, Alves Rosa MF, Minnucci FS, Chernavsky AC, Isturiz MA. N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-α (TNF-α) production in lipopolysaccharide (LPS)-stimulated human neutrophils. Clin Exp Immunol 1998; 113: 39-47.
102. Page SM, Gleich GJ, Roebuck KA, Thomas LL. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 1999; 21: 230-237.
103. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumour necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
104. Sibelius U, Hattar K, Hoffman S, et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. Crit Care Med 2002; 30: 2306-2312.
105. 2: a role for cell surface glycosaminoglycans. Biochem Pharmacol 2002; 63: 65-72.
106. Falt J, Dahlgren C, Ridell M. Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria. APMIS 2002; 110: 593-600.
107. 4. J Immunol 2001; 167: 2869-2878.
108. Koller M, Wick M, Muhr G. Decreased leukotriene release from neutrophils after severe trauma: role of immature cells. Inflammation 2001; 25: 53-59.
109. Hattar K, Sibelius U, Bickenbach A, Csernock E, Seeger W, Grimminger F. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis. J Leukoc Biol 2001; 69: 89-97.
110. Lindén A. Increased interleukin-8 release by β-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 1996; 119: 402-406.
111. Jorens PG, Richman-Eisenstadt JBY, Housset BP, et al. Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. Am J Physiol 1992; 263: L708-L713.
112. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms HH. Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery 1998; 124: 409-417.
113. Dunican AL, Leuenroth SJ, Grutkoski P, Ayala A, Simms HH. TNFα-induced suppression of apoptosis is mediated through interleukin-8 production. Shock 2000; 14: 284-288.
114. 2 antagonist S-1452 in guinea-pigs. Clin Exp Allergy 1995; 25: 51-59.
115. Hessel EM, Van Oosterhout AJ, Van Ark I, et al. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Crit Care Med 1997; 160: 325-334.
116. Amin K, Ludviksdottir D, Janson C, et al. Inflammation and structural changes in the airways of patients with atopic and non-atopic asthma. Am J Respir Crit Care Med 2000; 162: 2295-2301.
117. Mazarella G, Grella E, D'Auria D, et al. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-α in asthmatic patients. Allergy 2000; 55: 36-41.
118. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89: 1001-1009.
119. Yousefi S, Hemmann S, Weber M, et al. IL-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J Immunol 1995; 154: 5481-5490.
120. Hoshi H, Ohno M, Hinma M, et al. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy 1995; 25: 720-728.
121. Korn SH, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001; 17: 1070-1077.
122. 2-agonists and corticosteroids on tumour necrosis factor α-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 2000; 23: 79-85.
123. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992; 79: 45-51.
124. Lukacs BW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 1995; 86: 2767-2773.
125. Pizzichini MMM, Pizzichini E, Clelland L, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13: 15-21.
126. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995; 86: 3181-3188.
127. Yamasawa H, Oshikawa K, Ohno S, Sugiyama Y. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating GM-CSF release. Am J Respir Cell Mol Biol 2004; 30: 569-575.
128. Torisu M, Yoshida T, Ward PA, Cohen S. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes. J Immunol 1973; 111: 1450-1458.
129. O'Byrne PM, Inman MD, Adelroth E. Reassessing the Th2 cytokine basis of asthma. Trends Pharmacol Sci 2004; 25: 244-248.
130. Bochner BS, Busse WW. Advances in mechanisms of allergy. J Allergy Clin Immunol 2004; 113: 868-875.
131. Tomaki M, Zhao LL, Sjostrand M, Lindén A, Ichinose M, Lötvall J. Comparison of effects of anti-IL-3, IL-5 and GM-CSF treatments on eosinophilopoiesis and airway eosinophilia induced by allergen. Pulm Pharmacol Ther 2002; 15: 161-168.
132. Gavett SH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994; 10: 587-593.
133. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697-704.
134. Renzi PM, Yang JP, Diamantstein T, Martin JG. Effects of depletion of cells bearing the interleukin-2 receptor on immunoglobulin production and allergic airway responses in the rat. Am J Respir Crit Care Med 1996; 153: 1214-1221.
135. Rutgers SR, Postma DS, ten Hacken NH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12-18.
136. Turato G, Zuin R, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002; 166: 105-110.
137. Meshi B, Vitalis TZ, Ionescu D, et al. Emphysemateous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26: 52-57.
138. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-942.
139. Mishima H, Hojo M, Watanabe A, Hamid QA, Martin JG. CD4+ T cells can induce airway hyperresponsiveness to allergen challenge in the Brown Norway rat. Am J Respir Crit Care Med 1998; 158: 1863-1870.
140. De Sanctis GT, Itoh A, Green FHY, et al. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nature Med 1997; 4: 460-462.
141. Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cysteine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001; 20: 5332-5341.
142. Yao Z, Fanslow FC, Seldin MF, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3: 811-821.
143. Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169: 443-453.
144. National Center for Biotechnology Information. Entrez Gene. www. ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Search&DB=gene. Date last updated for IL-17: September 2 2004. Date last accessed: July 20 2004.
145. Li H, Chen J, Huang A, et al. Cloning and characterization of IL-17B and IL-17C: two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000; 97: 773-778.
146. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002; 169: 642-646.
147. Lee J, Ho W-H, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276: 1660-1664.
148. Kim MR, Manoukian R, Yeh R, et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002; 100: 2330-2340.
149. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001; 167: 4137-4140.
150. Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair: identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000; 275: 19167-19176.
151. Kawaguchi M, Onuchic LF, Li X-D, et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001; 167: 4430-4435.
152. Shin H, Benbernou N, Esnault S, Guenounou M. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 1999; 11: 257-266.
153. Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999; 162: 1246-1251.
154. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165: 6107-6115.
155. Happel KI, Zheng M, Young E, et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003; 170: 4432-4436.
156. Laan M, Palmberg L, Larsson K, Linden A. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002; 19: 534-537.
157. Shin HC, Benbernou N, Fekkar H, Esnault S, Guenounou M. Regulation of IL-17, IFN-γ and IL-10 in human CD8(+) cells by cyclic AMP-dependent signal transduction pathway. Cytokine 1998; 10: 841-850.
158. Chung DR, Kasper DL, Panzo RJ, et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003; 170: 1958-1963.
159. Yao Z, Spriggs M, Derry J, et al. Molecular characterisation of the human interleukin (IL)-17 receptor. Cytokine 1997; 9: 794-800.
160. Keehlen A, Thiele K, Rieman D, Langner J. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol 2002; 127: 539-546.
161. Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology 2001; 40: 522-527.
162. Prause O, Laan M, Lötvall J, Lindén A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003; 462: 193-198.
163. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002; 26: 748-753.
164. Awane M, Andres PG, Li DJ, Reinecker HC. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β -induced chemokine promoter activation in intestinal epithelial cells. J Immunol 1999; 162: 5337-5344.
165. Mori N, Oishi K, Sar B, et al. Essential role of transcription factor nuclear factor-kappa B in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cells. Infect Immun 1999; 67: 3872-3878.
166. Harper R, Wu K, Chang MM, et al. Activation of nuclear factor-kappa B in airway epithelial cells by thioredoxin but not N acetylcysteine and glutathione. Am J Respir Cell Mol Biol 2001; 25: 178-185.
167. Chang MM, Harper R, Hyde DM, Wu R. A novel mechanism of retinoic acid-enhanced interleukin-8 gene expression in airway epithelium. Am J Respir Cell Mol Biol 2000; 22: 502-510.
168. Kennedy T, Ghio AJ, Reed W, et al. Copper-dependent inflammation and nuclear factor-kappa B activation by particulate air pollution. Am J Respir Cell Mol Biol 1998; 19: 366-378.
169. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappa B in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998; 177: 1275-1281.
170. Bank U, Reinhold D, Kunz D, et al. Effects of interleukin-6 (IL-6) and transforming growth factor β (TGF-β) on neutrophil elastase release. Inflammation 1995; 19: 83-89.
171. Ottonello L, Frumento G, Arduino N, et al. Differential regulation of spontaneous and immune complex-induced neutrophil apoptosis by proinflammatory cytokines. Role of oxidants, Bax and caspase-3. J Leukoc Biol 2002; 72: 125-132.
172. Saba S, Soong G, Greenberg S, Prince A. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol 2002; 27: 561-567.
173. Schwander R, Yamaguchi K, Zhaodan C. Requirement of tumour necrosis factor receptor-associated factor (TRAF)-6 in interleukin-17 signal transduction. J Exp Med 2000; 191: 1233-1239.
174. Wuyts WA, Vanaudanaerde BM, Dupont LJ, Van Raemdock DE, Demedts MG, Verleden GM. N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung rejection? J Heart Lung Transplant 2004; 23: 122-127.
175. Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NFκB. J Biol Chem 1998; 273: 27467-27473.
176. Hoshino H, Lötvall J, Skoogh BE, Lindén A. Neutrophil recruitment by IL-17 into rat airways in vivo: role of tachykinins. Am J Respir Crit Care Med 1999; 159: 1423-1428.
177. Ye P, Garvey PB, Zhang P, et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med 2001; 25: 335-340.
178. Larsson R, Rocksén D, Lillienhook B, Jonsson A, Bucht A. Dose-dependent activation of lymphocytes in endotoxin-induced airway inflammation. Infect Immun 2000; 68: 6962-6969.
179. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 1998; 161: 6383-6389.
180. Schwarzenberger P, Huang W, Ye P, et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 2000; 164: 4783-4789.
181. Reynolds SJ, Donham KJ, Whitten P, Merchant JA, Burmeister LF, Popendorf WJ. Longitudinal evaluation of dose-response relationships for environmental exposures and pulmonary function in swine production workers. Am J Ind Med 1996; 29: 33-40.
182. Barzyk A, Pierzcha W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003; 97: 726-733.
183. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen disposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003; 113: 1803-1812.
184. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17: 375-387.
185. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 2002; 71: 1-8.
186. Dumont F. IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses. Expert Opin Ther Patents 2003; 13: 287-303.
187. Witovski J, Ksiazek K, Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004; 61: 567-579.